| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
|
Lancet Oncol
|
2009
|
9.90
|
|
2
|
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
|
N Engl J Med
|
2014
|
9.19
|
|
3
|
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
|
J Clin Oncol
|
2013
|
4.72
|
|
4
|
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.
|
J Clin Oncol
|
2013
|
3.52
|
|
5
|
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
|
Int J Radiat Oncol Biol Phys
|
2011
|
2.18
|
|
6
|
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
|
Neuro Oncol
|
2013
|
1.88
|
|
7
|
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.
|
J Clin Oncol
|
2013
|
1.62
|
|
8
|
Neurocognitive function before and after surgery for insular gliomas.
|
J Neurosurg
|
2011
|
1.44
|
|
9
|
Clinical trial end points for high-grade glioma: the evolving landscape.
|
Neuro Oncol
|
2011
|
1.42
|
|
10
|
The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.
|
J Clin Oncol
|
2003
|
1.36
|
|
11
|
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
|
Neuro Oncol
|
2008
|
1.23
|
|
12
|
Cancer as a risk factor for dementia: a house built on shifting sand.
|
J Natl Cancer Inst
|
2005
|
1.23
|
|
13
|
Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls.
|
Proc Natl Acad Sci U S A
|
2013
|
1.09
|
|
14
|
A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone.
|
Neurosurgery
|
2007
|
1.05
|
|
15
|
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
|
Lancet Oncol
|
2013
|
1.03
|
|
16
|
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
|
Lancet Oncol
|
2013
|
1.03
|
|
17
|
Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism.
|
Surgery
|
2009
|
0.98
|
|
18
|
Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.
|
Neuro Oncol
|
2012
|
0.98
|
|
19
|
Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.
|
Arch Clin Neuropsychol
|
2009
|
0.97
|
|
20
|
Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism.
|
Endocr Pract
|
2007
|
0.92
|
|
21
|
Congruence of primary brain tumor patient and caregiver symptom report.
|
Cancer
|
2012
|
0.88
|
|
22
|
Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
|
Cancer
|
2013
|
0.87
|
|
23
|
Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy.
|
J Int Neuropsychol Soc
|
2009
|
0.82
|
|
24
|
Relationship between neuropsychological test performance and productivity at 1-year following traumatic brain injury.
|
Clin Neuropsychol
|
2004
|
0.81
|
|
25
|
Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.
|
Brain Imaging Behav
|
2013
|
0.80
|
|
26
|
Chemotherapy and cognition: effects, potential mechanisms, and management.
|
Am J Ther
|
2006
|
0.80
|
|
27
|
Relationship between cognitive function and prognosis in glioblastoma.
|
CNS Oncol
|
2013
|
0.77
|
|
28
|
Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.
|
Neurosurgery
|
2015
|
0.75
|
|
29
|
Reply to v.R. Bhatt et Al and m.C. Chamberlain.
|
J Clin Oncol
|
2013
|
0.75
|